Search results
Health Department conducting survey about barriers in colon cancer screenings, treatment
The Times-Gazette via Yahoo News· 14 hours agoWhile there are stool-based test, like Cologuard, to look for colon cancer, and are often used as a...
Kate Middleton makes 1st public appearance in 6 months at Trooping the Colour amid cancer...
Yahoo Canada Style· 7 days agoEric Chen, a medical oncologist at Toronto's Princess Margaret Cancer Centre. What are GI cancers?...
Social media’s message about the sun and sunscreen: ‘It’s frightening’
CNN via Yahoo News· 1 day agoIn fact, a sunburn is much more than a red flag for a little sun damage. It’s a sign of actual cell...
Best-selling author Dr. Sharon Malone encourages North Texas women to be their own healthcare...
KDFW via Yahoo News· 2 days agoDr. Sharon Malone’s career as an OB/GYN has spanned more than 30 years in the private sector. She is...
The toxic truth about mouthwash
The Telegraph via Yahoo News· 5 days agoMore than a third of us use mouthwash, whether that’s just for an extra burst of minty freshness after brushing our teeth or to tackle bleeding gums....
Full body scans miss the mark when it comes to improving U.S. disease prevention
NPR· 5 days agoVaccine hesitancy and refusal are at higher rates than before the pandemic. Lack of awareness is an additional barrier. In my practice, I regularly see patients who don’t know that they are ...
Doctors Test Obesity Drugs’ Limits
The New York Times via Yahoo News· 4 days ago“I kept getting sicker and sicker.” She also had high blood pressure, and she was obese. Doctors told her to diet and exercise, which she did, to no...
Tucson Speaks Out: June 16 letters of the day
Arizona Daily Star· 6 days agoLetters to the Editor for June 16
Medical marijuana bill clears first vote in N.C. Senate
Winston-Salem Journal· 2 days agoThe 2024 attempt at reviving a bipartisan and controversial N.C. Senate medical marijuana bill...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 4 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
